Companies Dominating the Pharmacogenomics Testing Landscape
- PerkinElmer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Dynamic DNA Laboratories
- Sonic Healthcare
- QIAGEN
- Eurofins Scientific
- 23andMe, Inc
- OneOme
- Pacific Biosciences of California, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Pharmacogenomics Testing Market in 2025 is evaluated at USD 14 billion.
The global market size was over USD 13.06 billion in 2024 and is anticipated to witness a CAGR of around 9%, crossing USD 40.04 billion revenue by 2037.
North America is expected to garner USD 14.01 billion by 2037, attributed to increasing healthcare expenditure, the presence of manufacturers, and advancements in pharmacogenomics testing technologies.
The major players in the market include of Thermo Fisher Scientific Inc., Dynamic DNA Laboratories, Sonic Healthcare, QIAGEN, Eurofins Scientific, 23andMe, Inc.
